Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2001 | 1997 - 2001 | 2001 | 1997 - 2001 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 36 | 583.8 | 182 | 556.7 | 19 | 337.3** | 94 | 307.8 |
| Esophagus | * | # | 3 | # | * | # | 2 | # |
| Stomach | * | # | 2 | # | * | # | 1 | # |
| Colon excluding Rectum | * | # | 17 | 55.4** | * | # | 10 | 33.8** |
| Rectum and Rectosigmoid Junction | * | # | 8 | 25.0** | * | # | 2 | # |
| Liver | * | # | 1 | # | * | # | 0 | # |
| Pancreas | * | # | 5 | 19.7** | * | # | 7 | 26.6** |
| Lung and Bronchus | 7 | 115.5** | 40 | 127.1 | 8 | 128.8** | 39 | 122.3 |
| Melanoma of the Skin | * | # | 4 | # | * | # | 0 | # |
| Prostate | 9 | 153.4** | 55 | 164.1 | * | # | 2 | # |
| Urinary Bladder | * | # | 5 | 13.5** | * | # | 3 | # |
| Kidney and Renal Pelvis | * | # | 6 | 16.3** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 4 | # | * | # | 2 | # |
| Myeloma | * | # | 0 | # | * | # | 1 | # |
| Leukemia | * | # | 3 | # | * | # | 3 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2001 | 1997 - 2001 | 2001 | 1997 - 2001 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 36 | 429.3 | 161 | 400.0 | 21 | 239.3 | 71 | 167.3 |
| Colon excluding Rectum | * | # | 11 | 24.6** | * | # | 8 | 16.4** |
| Rectum and Rectosigmoid Junction | * | # | 10 | 22.9** | * | # | 1 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 2 | # | * | # | 4 | # |
| Lung and Bronchus | 7 | 83.2** | 25 | 61.0 | 9 | 109.2** | 20 | 46.6 |
| Melanoma of the Skin | * | # | 1 | # | * | # | 0 | # |
| Breast | 7 | 86.3** | 42 | 106.8 | * | # | 4 | # |
| Cervix Uteri | * | # | 5 | 13.7** | * | # | 1 | # |
| Corpus Uteri | * | # | 10 | 24.8** | * | # | 1 | # |
| Ovary | * | # | 10 | 25.8** | * | # | 6 | 15.2** |
| Urinary Bladder | * | # | 8 | 19.0** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 4 | # | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 8 | 20.2** | * | # | 4 | # |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 3 | # | * | # | 3 | # |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, February 2005
Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
